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cartilage changes. Calcitonin is well-known for its inhibitory actions on
osteoclasts and bone resorption. We investigated the effect of endogenous
increased levels of salmon calcitonin (sCT) on the articular cartilage and
subchondral bone, after destabilization of the medial meniscus (DMM) in
normal and sCT over-expressing mice.
Methods: Mice over-expressing sCT and wild-type littermates were used
for the experiments. Genotyping was performed by measuring the cir-
culating serum levels of sCT by ELISA. Northern Blot expression analysis
was carried out to investigate the liver-speciﬁc expression. Non-decalciﬁed
plastic embedded vertebrae from mice of 6 and 12 month of age were used
for histomophometric investigations. Serum samples were collected for
osteocalcin measurements and urine for Dpd/creatinine measurements. For
evaluation of cartilage and subchondral bone changes, forty-four 10 week
old mice were divided into four groups and subjected to destabilization
of the medial meniscus (DMM) or sham operation. After 7 weeks the
study was terminated and the knee joints isolated for histological analysis
by Safranin’O staining and biochemical markers were measured in fasting
blood samples. The proteoglycan volume of the tibia and femur was quan-
titative assessed from histology sections by using the VisioPharm image
technology. Individual pixels were labeled for multiple variables including
bone, proteoglycans and bone marrow to create a working algorithm. Still
images were taken of the knee joint histology sections and the images were
processed and classiﬁed by masking the area of interest. The algorithm was
then applied to the processed area for calculating proteoglycan loss.
Results: Transgenic mice had >800 pg/mL serum sCT and wild-type mice
had no detectable levels. Von Kossa staining revealed an increase in trabec-
ular bone volume (BV/TV) of 100% after 6 month and 150% after 12 month
in sCT mice when compared to controls (P<0.05). Trabecular number
and thickness increased signiﬁcantly in transgenic mice of both 6 and 12
months of age (P<0.05), and trabecular separation decreased (P<0.05). Os-
teoblasts number, bone formation rate and osteocalcin measurements was
not affected in transgenic mice. Wild-type DMM operated mice had major
damage to the articular cartilage, compared to DMM operated transgenic
mice. In wild-type animals a 5-fold increase in the quantitative erosion
index was observed after DMM, and the semi-quantitative OARSI score
showed more than 400% (P<0.001) increase, compared to sham-operated
wild-type. DMM operated transgenic mice were protected against cartilage
erosion and showed a 65% and 64% (P<0.001) reduction, respectively, for
the two histopathological evaluation methods, compared to DMM wild-
type littermates. Preliminary quantitative analysis of proteoglycan loss
revealed a trend towards sCT protection against cartilage erosion, with
DMM operated WT mice showing a 40% increase in proteoglycan loose
compared to WT sham, while DMM operated sCT mice showed a 20%
reduction compared to sCT sham. DMM operated WT mice showed a 30%
reduction in proteoglycans compared to sCT DMM.
Conclusions: sCT over-expressing mice had higher bone volume compared
to wild-type, and were protected against cartilage erosion compared to
wild-type litter mate controls. This data suggest that increased levels of sCT
may hamper the pathogenesis of OA however more studies are necessary
to conﬁrm these preliminary results.
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EFFECTS OF DYNAMIC LOADING ON INJURED ARTICULAR CARTILAGE IN
VITRO AND IN VIVO
R.E. Miller1, Y. Li1, J. Li2, A.-M. Malfait2, J. Sandy2, A. Plaas2, H.-H. Hung1,
E. Frank1, A. Grodzinsky1
1MIT, Cambridge, MA; 2Rush Univ. Med. Ctr., Chicago, IL
Purpose: Recent clinical studies in patients showed that ACL deﬁciency
not only shifts tibiofemoral contact location but signiﬁcantly increases
the magnitude of cartilage contact deformation: from 10-20% compressive
deformation in contralateral normal knees to 20-30% in ACL-deﬁcient knees
of the same patients. In addition, previous in vitro models have shown that
mechanically injured cartilage cultured in the presence of inﬂammatory
cytokines, known to be upregulated in human synovial ﬂuid after joint
injury, potentiates matrix catabolism. The purpose of this study was to ex-
amine whether increased loading after injury further exacerbates cartilage
degradation using both in vitro and in vivo models.
Methods: In vitro studies: Bovine cartilage explants (3mm diam x 1mm
thick disks) were subjected to a single radially-unconﬁned compression
to 50% ﬁnal strain at a velocity of 1 mm/second (100%/second strain
rate). Explants were then incubated with TNF-α (10 ng/mL) and IL-6/sIL-6R
(20/100 ng/mL) over 8 days. Intermittent dynamic compression was applied
from days 2-8 (0.5 Hz haversine waveform, 1 hr on, 5 hr off, 4 times
per day), with dynamic compression amplitude varying from 0-30%, n=6
disks per condition. In vivo studies: IACUC approval was given by Rush
University. Ten week old C57Bl/6 male mice were subjected to a surgical
Destabilization-Induced Joint Injury (DMM) model developed by Glasson
et al., alone or in combination with TM running (14 days 15° incline, 32
cm/sec, 20 min per day, for 2 weeks starting on day 4 post-surgery). For
DMM surgery, the anterior medial meniscotibial ligament was completely
severed. Control mice were subjected to only cage activity. At 3 weeks post
surgery, mice were euthanized and joints were stained with India Ink for
gross observations or protein was extracted for Luminex (23-plex mouse
cytokine kit), n=3 per condition. Statistics: Data were analyzed by ANOVA
with Tukey post-hoc test, p<0.05. Luminex data were normalized to the
total protein extracted per joint.
Results: In vitro studies: Dynamic compression applied to bovine cartilage
initially subjected to injury and cytokine treatment caused additional loss
of matrix GAG that increased with dynamic compression amplitude in a
dose-dependent manner (ANOVA, p<0.05). In vivo studies: C57Bl/6 mice
developed marked cartilage roughening and lesions 18 days post DMM
surgery on the medial aspects of the operated joint, and ﬁbrotic remodeling
along the tibial and femoral joint margins was readily detected. The DMM
model alone resulted in signiﬁcantly elevated levels of IL-1β, G-CSF, KC
(mouse IL-8-related), and MCP-1 compared to controls. With DMM+TM,
the extent of erosion near the patellar groove was much more severe on
both the lateral and medial sides and was accompanied by an additional
ﬁbrous ingrowth from the margins. Along with the increased joint damage,
DMM+TM resulted in signiﬁcantly increased protein levels of G-CSF, IL-1β
and KC (murine related IL-8) over controls; IL-9 and IFN-γ were signiﬁ-
cantly decreased compared to controls. RANTES was increased over DMM
alone.
Conclusions: In this study, we showed that dynamic compression further
increases GAG loss from injured cartilage explants in a dose-dependent
manner. Additionally, a murine mimic of knee joint injury followed by
dynamic loading revealed signiﬁcantly different levels of speciﬁc inﬂam-
matory cytokines that have been previously found in human synovial ﬂuid
post-injury. These results demonstrate the potential usefulness of these in
vitro and in vivo models for studying the mechanisms underlying cartilage
degradation following joint injury and for testing the effects of therapeutics
to ameliorate this degradative response.
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HIF2A/NF-κB SIGNAL IN CHONDROCYTES CONTROLS EXTENSIVE STEPS OF
OSTEOARTHRITIS DEVELOPMENT IN MICE AND HUMANS
A. Fukai, T. Saito, A. Mabuchi, T. Ikeda, F. Yano, S. Ohba, N. Nishida,
T. Akune, N. Yoshimura, T. Nakagawa, K. Nakamura, K. Tokunaga,
U.-i. Chung, H. Kawaguchi
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Purpose: Endochondral ossiﬁcation is a crucial process not only for skeletal
growth but also for osteoarthritis (OA) development. This process starts
from chondrocyte hypertrophy characterized by type X collagen (COL10A1)
expression, which is followed by cartilage degradation, vascularization, and
osteogenesis. This study sought to identify the molecular mechanism that
extensively controls these sequential steps in mice and humans.
Methods: We performed screenings of transcription factors using chon-
drogenic ATDC5, OUMS27 and SW1353 cells transfected with luciferase-
reporter constructs containing the target promoters. For functional studies,
we used stable lines of ATDC5 cells with retroviral overexpression of
the genes, the dominant negative mutants, the siRNA, and the mutants
at the oxygen-dependent hydroxylation residues. Promoter analyses were
performed by luciferase assay, electrophoretic mobility shift assay, and
chromatin immunoprecipitation assay using the chondrogenic cells above.
An experimental OA model was created surgically by inducing instability
in the knee joints of 8-week-old mice, and OA severity was quantiﬁed
by the OARSI histopathology grade. Human joint cartilage was obtained
as surgical specimens of total knee arthroplasty. Using a population-based
cohort of the ROAD study, we searched for common SNPs with minor allele
frequency >0.1 in the 1.5 kb 5’UTR of the human gene, and genotyped the
SNP by RFLP.
Results: A COL10A1 promoter assay identiﬁed hypoxia-inducible factor 2α
(HIF2A) as the most potent transactivator among transcription factors ex-
pressed in chondrocytes. The HIF2A expression increased with chondrocyte
differentiation in cultured ATDC5 cells and in the mouse limb cartilage,
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as well as with OA progression in the knee joint cartilages of the mouse
experimental model and human surgical specimens. In all systems, the
expression was associated with factors related to endochondral ossiﬁcation
such as COL10A1, MMP3, 9, 13, VEGF, Indian hedgehog, PTH/PTHrP type I
receptor, and Runx2. HIF2A enhanced promoter activities of these factors
through speciﬁc binding to the respective hypoxia-responsive elements.
The Hif2a heterozygous deﬁcient (Hif2a+/-) mice exhibited slight growth
retardation and notable resistance to OA development with decreased
expressions of all factors above. The loss- and gain-of-function analyses in
the cultures of ATDC5 cells and primary Hif2a+/- chondrocytes revealed
that HIF2A was crucial for endochondral ossiﬁcation, independently of the
oxygen-dependent hydroxylation. Our further study on the upstream signal
using the HIF2A promoter assay identiﬁed RELA, an NF-κB family member,
as the most potent transactivator, and determined an NF-κB motif as the
core responsive region by mutagenesis analysis. TNF-α and IL-1β, putative
ligands for the NF-κB signal, increased the HIF2A expression in chondro-
genic cells. In the mouse joint cartilage, the RELA expression was induced
alongside the HIF2A expression during OA development. Finally, we have
identiﬁed one common SNP (rs17039192; +18C/T) in 5’UTR of the human
HIF2A gene in the ROAD population-based cohort, and the case-control
association study using individuals over 50 years of age with (K/L grade
≥ 3; n=397) and without (K/L≤1; n=437) knee OA showed a signiﬁcant
association of this SNP with knee OA (P=0.013, odds ratio=1.44). The HIF2A
promoter containing the susceptibility allele (18C) showed higher trans-
activity than that containing 18T in chondrogenic cells with and without
the RELA co-transfection; however, the difference was abrogated by the
mutagenesis in the responsive NF-κB motif above, indicating the mediation
of HIF2A transactivation by the NF-κB signal in the regulation of OA by the
SNP.
Conclusions: The HIF2A/NF-κB signal controls extensive steps of endo-
chondral ossiﬁcation in OA development of mice and humans, so that this
signal may represent a therapeutic target for OA.
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A POSITIVE ROLE OF DBC1, A SIRT1 REPRESSOR, IN THE ARTHRITIC
RESPONSE IN HUMAN CHONDROCYTES
O.H. Gabay1, E. Lee1, R. Booth1, V. Gagarina1, M. Dvir-Ginzberg2, D.J. Hall1
1NIH, Bethesda, MD; 2Lab. of Cartilage Biology, Inst. of Dental Sci., Faculty of
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Purpose: Osteoarthritis (OA) is a multi-factorial disease featuring an imbal-
ance between cartilage anabolism and catabolism. Chronic inﬂammatory
stress contributes to enhanced matrix degradation and chondrocyte apop-
tosis in OA cartilage. We have shown that SirT1, a protein deacetylase
known to prolong lifespan, is able to enhance both chondrocyte viability
and cartilage speciﬁc gene expression. Here we evaluate the ability of DBC1
(Deleted in Breast Cancer 1), a repressor of SirT1, to regulate expression of
the cartilage-speciﬁc genes collagen type 2 and aggrecan.
Method: Overexpression of DBC1 and Sirt1 in human osteoarthritic chon-
drocytes were performed by Amaxa electroporation. Antibodies against
Sirt1 (Millipore), aggrecan, collagen 2, (Santa Cruz) and DBC1 (Abcam) were
used in immunoblotting, immunohistochemistry and immunoprecipitation.
PCR utilized aggrecan, collagen type 2, GAPDH primers and Taqman PCR
mix (Applied Biosystem)
Results: Overexpression of SirT1 in human chondrocytes led to enhanced
expression of aggrecan and collagen type 2. Further, SirT1 repress expres-
sion of many matrix metalloproteinases (MMPs). In contrast, tissue sections
from OA patients revealed reduced protein levels of SirT1 and aggrecan
and collagen type 2, with elevated levels of MMPs. We ﬁnd that DBC1
is upregulated in OA cartilage compared to Normal cartilage. Moreover,
when expressed in human chondrocytes, DBC1 represses these aggrecan
and collagen type 2. Further, DBC1 is upregulated by TNFα in chondrocytes
where cartilage genes are repressed and MMPs are elevated.
Conclusion: Our results indicate that the longevity protein SirT1 is a pos-
itive regulator of cartilage matrix in chondrocytes. Further, DBC1 displays
characteristics of a pro-arthritic protein, due to its ability to block SirT1
enzymatic activity. That DBC1 is upregulated in OA and is induced by TNFα.
Thus SirT1 has features of an anti-osteoarthritic enzyme, consistent with
its ability to reduce the severity of age-associated diseases.
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THE EXPRESSION OF THE ANTI-APOPTOTIC TRANSCRIPTION FACTOR
NF-kappaB-P65 IS MARKEDLY DIMINISHED IN CHONDROCYTES OF
MURINE OSTEOARTHRITIC CARTILAGE AND IN A SUBSET OF HUMAN
OSTEOARTHRITIC CARTILAGE SAMPLES
O.J. Arntz, M.B. Bennink, E.N. Blaney-Davidson, P.M. Kraan, W.B. van den
Berg, F.A. van de Loo
Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Purpose: Chondrocytes play a central role in cartilage pathology as seen
in rheumatoid arthritis (RA) and osteoarthritis (OA) patients by a deranged
synthesis of extracellular matrix (ECM) components and the enhanced
release of ECM destructive metalloproteinases (MMPs). Nuclear factor-
kappaB (NF-kappaB) is an important transcription factor in the regulation
of MMPs, but is also regarded as a survival factor in cells. We studied the
regulation of NF-kappaB-P65 in chondrocytes in rheumatoid arthritis, os-
teoarthritis, mouse models of arthritis and osteoarthritis and the functional
consequences of decreased level of NFkappaB-P65.
Methods: We measured the level of NF-kappaB-P65 in freshly isolated
chondrocytes of arthritic cartilage obtained from joint replacement surgery,
cartilage of a spontaneous osteoarthritis mouse model (STR/ORT), cartilage
of a streptococcal cell wall- and antigen-induced arthritis and cartilage
from young (14 weeks) and old (>12 months) mice by Western blotting,
immunohistochemistry or RT-qPCR. To study the functional consequences
of decreased level of NF-kappaB-P65 in chondrocytes the murine H4
chondrocyte-cell line was stably transduced with a lentivirus expressing
a short-hairpin RNA against NF-kappaB-P65 to reduce the NF-kappaB-P65
protein levels by a RNA interference approach. We selected several celllines
that expressed different amounts of NF-kappaB-P65 protein. To study the
biological consequences, conditioned medium of OA synovium was added
to the murine chondrocyte cell line with the lowest NF-kappaB-P65 level.
Results: In all chondrocytes of RA patients high NF-kappaB-P65 levels
were detected, by immunohistochemistry and Western blot, whereas in
chondrocytes of a subset of OA cartilage samples levels were unexpected
low (6 out of 12). In mouse models the level of NF-kappaB-P65 showed the
same regulation. NF-kappaB-P65 levels in cartilage from murine arthritis
models was increased up to 250% at day 2 after induction of streptococcal
cell wall- or antigen-induced arthritis and at day 7 returned to the basal
level of naive knee joints, whereas in STR/ORT mice levels were diminished
more than 75% when joints became affected, as determined by immunohis-
tochemistry. Levels of NF-kappaB-P65 in young and old mice were equal,
but the older groups showed more variation, detected by immunohisto-
chemistry. In vitro, we selected chondrocyte cell-lines with different levels
of NF-kappaB-P65. By adding TNFalpha, cell death was only induced in the
cells with low levels of NF-kappaB-P65, as detected by 7-AAD staining.
A clear negative correlation between TNFalpha induced cell death and
the levels of NF-kappaB-P65 in chondrocyte cell-lines was found. Adding
conditioned medium of synovial explants from different OA patients to
the murine chondrocyte cell-line with the lowest NF-kappaB-P65 level,
resulted in more than 60% chondrocyte death in 3 of the 5 conditioned
medium samples tested which could be prevented by preincubation of
these media with soluble-TNFR1 (Enbrel). TNFalpha was detected using a
Luminex assay in the same samples that caused cell death.
Conclusions: This study clearly demonstrated that lower levels of NF-
kappaB-P65 makes chondrocytes more vulnerable for TNFalpha, a cytokine
which can be produced during OA, and that this anti-apoptotic transcrip-
tion factor is downregulated in chondrocytes in murine OA and in 50% of
OA patients.
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RESPONSIVENESS AND RELIABILITY OF MRI IN OSTEOARTHRITIS:
ANALYTIC LITERATURE REVIEW
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Purpose: To summarize literature on the responsiveness and reliability of
MRI-based measures of osteoarthritis (OA) structural change.
Methods: An online literature search was conducted of the OVID, EMBASE,
CINAHL, PsychInfo and Cochrane databases of articles published up to the
